EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H15ClN4 |
| Net Charge | 0 |
| Average Mass | 346.821 |
| Monoisotopic Mass | 346.09852 |
| SMILES | Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1 |
| InChI | InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25) |
| InChIKey | YCOYDOIWSSHVCK-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1). vascular endothelial growth factor receptor antagonist An antagonist at the vascular endothelial growth factor receptor. |
| Applications: | ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antifibrotic agent Any agent which acts to reduce fibrosis. angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| vatalanib (CHEBI:90620) has role angiogenesis inhibitor (CHEBI:48422) |
| vatalanib (CHEBI:90620) has role antifibrotic agent (CHEBI:233423) |
| vatalanib (CHEBI:90620) has role antineoplastic agent (CHEBI:35610) |
| vatalanib (CHEBI:90620) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434) |
| vatalanib (CHEBI:90620) has role ophthalmology drug (CHEBI:66981) |
| vatalanib (CHEBI:90620) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| vatalanib (CHEBI:90620) is a monochlorobenzenes (CHEBI:83403) |
| vatalanib (CHEBI:90620) is a phthalazines (CHEBI:38768) |
| vatalanib (CHEBI:90620) is a pyridines (CHEBI:26421) |
| vatalanib (CHEBI:90620) is a secondary amino compound (CHEBI:50995) |
| Incoming Relation(s) |
| vatalanib succinate (CHEBI:90623) has part vatalanib (CHEBI:90620) |
| IUPAC Name |
|---|
| N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine |
| INNs | Source |
|---|---|
| vatalanib | WHO MedNet |
| vatalanib | WHO MedNet |
| vatalanib | WHO MedNet |
| vatalanib | WHO MedNet |
| Synonyms | Source |
|---|---|
| BAY-86-5127 | ChEMBL |
| CGP 79787 | ChemIDplus |
| CGP-79787 | ChemIDplus |
| CGP79787 | ChEBI |
| N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine | ChemIDplus |
| N-(p-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine | ChEBI |
| Registry Numbers | Sources |
|---|---|
| Reaxys:8638800 | Reaxys |
| CAS:212141-54-3 | ChemIDplus |
| Citations |
|---|